Osicka MRM, Gruszycki KMR, Tauguinas PAL, Soro MAS, Alba DDA, Gruszycki KAE

Language: Spanish
References: 9
Page: 89-95
PDF size: 178.21 Kb.

ABSTRACT

Introduction: knowing toxicity associated to the use of drugs is a particular concern for patients, prescribers, providers and regulators. The adverse reactions are a major cause not only for medical consultation but also for hospitalization and sometimes bring about death.
Objective: to conduct the evaluation of notification of adverse drug reactions.
Methods: retrospective, cross-sectional and descriptive study. The reporting of adverse drug reactions from 2006 through 2012 were evaluated, based on the data from received reports contributed by both public and private hospitals and health centers in Chaco province, Argentina, as peripheral effectors of the National Pharmacovigilance System. The yearly reporting rate of adverse reactions per one million inhabitants was estimated.
Results: in this period, a total of 535 reports of adverse drug reactions were received, thus obtaining an average of 77 reports per year and a reporting rate of 73 reports per one million inhabitants. Regular behavior of some indicators was observed every year, as the prevalence of adverse reactions in females, the gastrointestinal system and skin disorders, among the most reported, and the prevalence of β-lactam antibiotics, ACE inhibitors and NSAIDs as the most reported groups of drugs. Regarding intensity and accountability, the moderate and the probable ones prevailed respectively.
Conclusion: although the yearly rate of adverse drug reactions in Chaco, Argentina is low, the achieved results are an important contribution to their knowledge in the above-mentioned region.

REFERENCES

1. Ministerio de Salud. Secretaría de Políticas, Regulación e Institutos. A.N.M.A.T. Guía de Buenas Prácticas de Farmacovigilancia. 2009. Buenos Aires: A.N.M.A.T.; 2009 [citado 15 Feb 2013]. Disponible en: http://www.anmat.gov.ar/farmaco/GUIA_BPFV.pdf

2. WHO. International monitoring of adverse reactions to drugs: adverse reaction terminology. WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, 1992.

3. WHO. Collaborating Centre for Drug Statistics Methodology. [cited 2013 Jan 10]. Available from: http://www.whocc.no/atc_ddd_index/

4. López CR, Aleksick A, Florentín Portillo, RD, Giménez, SL, Bertollo RL, Grenón F, Valsecia M. Monitorización de reacciones adversas causadas por medicamentos en el servicio de emergencia del Hospital Escuela Gral. José de San Martín. 2002 [citado 20 Feb 2013]. Disponible en: http://www.unne.edu.ar/cyt/2002/03- Medicas/M-025.pdf

5. Medina MA, Puche E, de Dios LJ. Factores asociados con la presentación de reacciones adversas a medicamentos en pacientes que acuden al servicio de urgencia de un hospital general: estudio de casos y controles. Aten Primaria. 2000;26(1):42-4.

6. Debesa García F, Jiménez G, Ávila Pérez J, González B, Pérez Peña J, Fernández Argüelles R. Principales resultados del sistema cubano de Farmacovigilancia en el año 2004. Rev Cubana Farm [Internet] 2005 Dic [citado 10 Mar 2013];39(3). Disponible en: http://scielo.sld.cu/pdf/far/v39n3/far05305.pdf

7. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica. Informe anual 2011 del Departamento de Farmacovigilancia. A.N.M.A.T. 2011 [citado 6 Feb 2013]. Disponible en: http://www.anmat.gov.ar/farmacovigilancia/docs/Informe_2011.pdf

8. Asulay MB, Kart AM, Napoli MN, Aróstegui SM, Valsecia ME. Estudio de las reacciones adversas a medicamentos en un servicio de emergencia hospitalario de la ciudad de Resistencia-Chaco. 2005 [citado 21 Feb 2013]. Disponible en: http://www.unne.edu.ar/unnevieja/Web/cyt/com2005/3-Medicina/M-078.pdf

9. Puche Cañas E, Luna del Castillo JD. Reacciones adversas a medicamentos en pacientes que acudieron a un hospital general: un meta-análisis de resultados. An Med Intern (Madrid) [Internet] 2007 [citado 25 Feb 2013];4 (12):574-578. Disponible en: http://scielo.isciii.es/pdf/ami/v24n12/original2.pdf